Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Muscles can make their own androgens, which may help muscle growth.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.